Shanti Pather, Alexander Muik, Ruben Rizzi, & Federico Mensa. (2023). Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: The early Omicron era. Taylor & Francis Group.
Chicago Style (17th ed.) CitationShanti Pather, Alexander Muik, Ruben Rizzi, and Federico Mensa. Clinical Development of Variant-adapted BNT162b2 COVID-19 Vaccines: The Early Omicron Era. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationShanti Pather, et al. Clinical Development of Variant-adapted BNT162b2 COVID-19 Vaccines: The Early Omicron Era. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.